Migden, Michael, John Lear, Nicholas Squittieri, Li Liu, Alexander Guminski, and Reinhard Dummer. 2020. “Duration of Response and Progression-Free Survival With Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients With Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind”. SKIN The Journal of Cutaneous Medicine 4 (5):s68. https://doi.org/10.25251/skin.4.supp.67.